Analysts Split on Health In Tech as Loss Estimates Widen
Wall Street's read on Health In Tech, Inc. (NASDAQ: HIT) is anything but unanimous, and the latest research note from Maxim Group only sharpens that divide. Analyst A. Klee is projecting a per-share